Posts filtered by tags: Coronavirus Vaccine[x]


 

Scientists are aiming to launch a nationwide trial 'as soon as possible' to find out if the top coronavirus vaccines can stop the virus from spreading

A 16-year-old participates in Pfizer's clinical trial to test its coronavirus vaccine candidate. Cincinnati Children’s Hospital Massive studies have shown that two leading coronavirus vaccines are highly effective at preventing people from getting sick with COVID-19, the disease caused by the coronavirus. Top researchers are already pitching plans for additional studies, Business Insider has learned. This research aims to answer a critical question: can these experimental shots also pr...
Tags: Science, US, Trends, Healthcare, Philadelphia, University of Pennsylvania, Pfizer, University Of North Carolina, Cohen, Corey, UNC, Children s Hospital, National Cancer Institute, Paul Offit, NCI, Lowy


The head of the US government program tasked with getting the country vaccines said he will probably quit by early next year — before most Americans can get a shot

Moncef Slaoui speaks at a vaccine development event in the White House in May 2020. Jabin Botsford/The Washington Post via Getty Images The head of Operation Warp Speed, the US government's program to help develop and roll out a COVID-19 vaccine to the country, said he may leave the position before the point when most Americans would be vaccinated. Moncef Slaoui, told Politico that he could step down from the position "by the end this year or early next year." Ordinary Americans would like...
Tags: Politics, Washington Post, White House, Politico, US, Trends, Healthcare, News UK, Biden, Jabin Botsford, Slaoui, Moncef Slaoui, Coronavirus, Coronavirus Vaccine, Operation Warp Speed, Sinead Baker


Privacy Advocates Flag Concerns About Possible Government-Required Proof Of Coronavirus Vaccine

cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4902973","autoplay":false,"accessKey":"5VD6Eyd6djewbCmNwBFnsJj17YAvGRwl","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"[email protected]","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrack...
Tags: News, Local, Seen On, Sacramento, Cbs, Ticketmaster, Schwartz, The World Health Organization, Adam Schwartz, Coronavirus, COVID, Coronavirus Vaccine, Rio Linda County Public Health, Rocklin Church Holds Packed Indoor Services, Electronic Frontier Foundation The CDC, Sabrina Cater


6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results

A lower initial dose of the Oxford-AstraZeneca vaccine, would mean double the number of vaccine doses available, once regulators approve it. VINCENZO PINTO/AFP via Getty Images For the third consecutive Monday, a drugmaker said its coronavirus vaccine candidate was successful in late-stage studies. AstraZeneca and the University of Oxford said their two-dose shot was effective at preventing COVID-19, according to preliminary results.  AstraZeneca's news follows similar announcements of suc...
Tags: Health, UK, Science, US, Trends, Getty Images, Analysis, Healthcare, Oxford, Brazil, Astrazeneca, Pfizer, University of Oxford, Biotech, Afp, Pollard


Elon Musk has surpassed rival Bill Gates as the world's second-richest person. Here's where their simmering feud began and how it's escalated amid the pandemic.

Elon Musk and Bill Gates. Susan Walsh/AP; Mike Cohen/Getty Images for The New York Times Elon Musk and Bill Gates have been feuding over everything from the coronavirus to electric vehicles. The two moguls don't see eye to eye on electric-car technology. Musk has said Gates doesn't know what he's talking about, and Gates has said he bought a Porsche electric car over a Tesla. This year, Gates and Musk have feuded over the coronavirus. Gates called Musk's comments on the outbreak "outrageou...
Tags: Amazon, Spacex, Elon Musk, Microsoft, Washington, US, Trends, Tech, Tesla, Nasa, Features, Harvard University, Porsche, International Space Station, Electric Vehicles, New York Times


Oxford and AstraZeneca's COVID-19 vaccine is considerably cheaper and easier to distribute than either Pfizer's or Moderna's. Here's why.

A half-dose of Oxford-AstraZeneca's COVID-19 vaccine initially could mean we have double the number doses available when it's approved by regulators. Siphiwe Sibeko/Pool via AP The University of Oxford and AstraZeneca's COVID-19 vaccine can be stored at normal fridge temperatures for at least six months. Unlike Pfizer and BioNTech's vaccine, it therefore doesn't require an ultra-cold storage and transport system, making it cheaper to distribute globally. The price per dose is also ...
Tags: Minnesota, US, Trends, Eu, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Welt am Sonntag, Andrew Pollard, Moderna, Siphiwe Sibeko, Stéphane Bancel


AstraZeneca and Oxford University announced a 3rd working COVID-19 vaccine, which they say is 70% effective

Researchers said the trial of more than 20,000 volunteers showed the vaccine stopped people from developing symptoms about 70% of the time on average. Carol Smiljan/NurPhoto via Getty Images The University of Oxford and AstraZeneca released positive results for their COVID-19 vaccine on Monday. In a statement, they said the vaccine is 70% effective on average. It follows results being released for two other vaccines — developed by Pfizer and Moderna — which are 95% effective. The Oxford/As...
Tags: Europe, Japan, UK, Science, Trends, Bbc, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, European Medicines Agency, EMA, Moderna, Coronavirus, COVID-19


Stephen Moore says that Trump will leave office 'triumphant,' comparing him to Winston Churchill

Stephen Moore. Samuel Corum/Getty Images Stephen Moore, a conservative economist, said in a Sunday radio interview that President Donald Trump would leave office on a high note due to the progress with COVID-19 vaccines and the economy. Moore touted the president's handling of the coronavirus with New York businessman John Catsimatidis. "I think he is going to leave the office triumphant," Moore said of the president. "By early next year, we will have a vaccine that nobody thought was poss...
Tags: Politics, New York, US, Trends, Georgia, Joe Biden, Economy, Winston Churchill, Pfizer, Gdp, Parliament, Conservative Party, Biden, Donald Trump, Churchill, Trump


We're likely to need coronavirus booster shots after the initial vaccine

A volunteer receives an experimental coronavirus shot from a medical worker at Baragwanath Hospital in Soweto, South Africa, June 24, 2020. REUTERS/Siphiwe Sibeko People may need to get booster shots after the initial coronavirus vaccine doses in order to stay protected, experts say. Other vaccines, like the tetanus shot, also require periodic boosters.  That adds further complication to the impending challenge of distributing coronavirus vaccines, which are likely to require two doses. Vi...
Tags: Health, Science, News, New York City, Trends, Pfizer, University of Oxford, Vaccines, Mount Sinai, Chicago Illinois, Soweto South Africa, Icahn School of Medicine, ORENSTEIN, Moderna, Siphiwe Sibeko, Aylin Woodward


Pfizer just asked the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receiving an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech requested that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization, they announced Friday. The vaccine was found to be 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might ...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Albert Bourla


US stocks waver as stimulus friction and rising virus cases overshadow vaccine hopes

Reuters / Lucas Jackson US stocks fluctuated on Friday as soaring COVID-19 cases and disagreement on new stimulus offset positive developments for vaccine distribution.Pfizer and BioNTech both gained ahead of plans to apply for emergency-use authorization for their experimental coronavirus vaccine. The FDA's vetting process is set to take a few weeks, teeing the shot up for an early 2021 rollout.The US reported a record 182,832 new COVID-19 cases on Thursday, according to The COVID Trackin...
Tags: US, Trends, Markets, Tesla, Bank Of America, Bitcoin, Economic recovery, Treasury, World Health Organization, Oil Price, Fda, Pfizer, Federal Reserve, Stimulus, Gold Price, S&P 500


Pfizer is about to ask the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech are about to request that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization. The vaccine was 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might take weeks to review the...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Allana Akhtar


Facebook, Twitter, and Google are uniting to stop vaccine misinformation from spreading online

A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine. Janssen Facebook, Twitter, and Google are all teaming up, in partnership with Canada and the UK, to stop misinformation about the coronavirus vaccine from spreading online.  British fact checking charity Full Fact convened the group, and plans to launch an initial framework in January 2021. According to polls, some Americans are skeptic about getting a coronavirus vaccine.  Dr. Anthony F...
Tags: Google, Facebook, Twitter, Europe, Elon Musk, UK, News, US, Trends, Spain, Canada, Healthcare, Food And Drug Administration, Associated Press, Pfizer, Conspiracy Theories


Moderna's CEO says vaccines aren't a 'silver bullet,' people must still social distance and wear masks

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump. Andrew Harnik/AP Images Wearing a mask and social distancing are the "best weapon" to control the virus, according to Moderna CEO Stéphane Bancel. Bancel spoke at the Bloomberg New Economy Forum on Thursday.  Moderna recently announced that its experimental vaccine was 94.5% effective against the new coronavirus. Bancel said in a recent interview with Business Insider that the public will have access to a vaccine by...
Tags: News, US, Trends, Bloomberg, Healthcare, Fda, Anthony Fauci, Chinese Center for Disease Control and Prevention, Moderna, Stéphane Bancel, Bloomberg New Economy Forum, Allana Akhtar, Coronavirus, Bancel, Coronavirus Vaccine, Covid-19 Vaccine


Oxford's COVID-19 vaccine is safe and produces an immune response in older adults, encouraging early trial results suggest

Kate Bingham, Chair of the Government's Vaccine Taskforce, after starting her Novavax trial at the Royal Free Hospital, north London on October 13, 2020. Kirsty O'Connor/PA Images via Getty Images Early trial results published in The Lancet suggest The University of Oxford and AstraZeneca's COVID-19 vaccine produces an immune response and is safe in older adults. This is important because older adults are more likely to develop severe cases of the virus, and some vaccines aren't as...
Tags: UK, Science, London, Trends, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Today programme, Pollard, Royal Free Hospital, Novavax, Andrew Pollard


Moderna and Pfizer's coronavirus vaccines are more than 94% effective. Here's how that compares to shots for flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer reported Wednesday that its coronavirus vaccine candidate was found to be 95% effective in preventing COVID-19 in clinical trials. Moderna's vaccine candidate was found to be 94.5% effective in trials. The chart below shows how the efficacy of those vaccine candidates compares to the effectiveness of...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Pfizer, Anthony Fauci, Johnson Johnson, Moderna, Andrew Dunn, BioNtech


Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval

University of Maryland Pfizer and BioNTech jumped on Wednesday trading after final analysis of trial data showed their coronavirus vaccine was 95% effective at protecting against COVID-19.Pfizer gained 4% at intraday highs, while BioNTech climbed as much as 8%. The news also helped drive major indexes higher.The companies now plan to apply for emergency-use authorization in a matter of days, setting the shot up for an early-2021 rollout.Watch Pfizer trade live here.Watch BioNTech trade liv...
Tags: US, Trends, Markets, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Oxford University, Biotech Stocks, Fed, Dalio, Jerome Powell, Moderna, PFE, BioNtech, Drug Trial


US stocks resume climb as investors cheer COVID-19 vaccine progress

Brendan McDermid/Reuters US stocks climbed on Wednesday after Pfizer and BioNTech revealed positive final-analysis data on their coronavirus vaccine.The companies' candidate was 95% effective at protecting against COVID-19 in trial patients, Pfizer said Wednesday. The firms plan to apply for emergency-use authorization "within days."The news lifted major indexes and spurred investors to push more cash into small-caps and cyclical stocks.Boeing surged after the Federal Aviation Authority ap...
Tags: US, Trends, Markets, Bank Of America, Bitcoin, Food And Drug Administration, Treasury, Oil Price, Pfizer, Nasdaq, Ba, Boeing, Dow Jones, Gold Price, Btc, S&P 500


Pfizer says its coronavirus vaccine is 95% effective as it gears up to ask the FDA to authorize the shot

A health care worker injects a patient with a syringe of an experimental coronavirus vaccine. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer's coronavirus vaccine candidate was 95% effective at protecting people against COVID-19, the pharmaceutical giant said in a Wednesday press release. Pfizer shared preliminary results from this late-stage study on November 9. Wednesday's release provided more details that come from the trial's final efficacy analysis. Pfizer began developin...
Tags: Health, Science, US, Trends, Healthcare, Fda, Pfizer, Biotech, Trump, US Food and Drug Administration, EUA, Pharmaceutical, Moderna, Peter Marks, Andrew Dunn, BioNtech


Trump is furious because he thinks Biden will get the credit for coronavirus vaccine developments, report says

President Donald Trump. Getty President Donald Trump is furious that President-elect Joe Biden's administration may take all the credit for the rollout of a coronavirus vaccine, according to The Daily Beast.  The president had hoped to brandish the success of Operation Warp Speed at packed, mask-free rallies during a second term, the outlet reported.  He has fixated on a successful vaccine to secure his legacy, and multiple reports suggest he pinned his reelection hopes on releasing one be...
Tags: Politics, Obama, White House, China, Barack Obama, Trends, Joe Biden, New York Times, Healthcare, News UK, Fda, Pfizer, Biden, Donald Trump, Centers For Disease Control And Prevention, The Daily Beast


Bill Gates says several more COVID-19 vaccine frontrunners will likely be highly effective, boosting worldwide access to a shot

Jeff Pachoud/AFP/Getty Images Success from two leading coronavirus vaccine programs likely means other frontrunners will also show strong protection against COVID-19, Bill Gates said Tuesday. Drug companies Pfizer and Moderna both announced late-stage success with their COVID-19 vaccines in the past 10 days. The billionaire Microsoft founder and philanthropist said that bodes well for other experimental shots. "With the very good news from Pfizer and Moderna, we think it's now likely that...
Tags: Health, Science, Microsoft, Trends, New York Times, Bill Gates, Healthcare, Astrazeneca, Pfizer, Gates, Johnson & Johnson, J J, Andrew Ross Sorkin, Novavax, Jeff Pachoud, Moderna


Pfizer picks 4 US states to trial transporting its COVID-19 vaccine at temperatures far below freezing. It's a key test of the 'cold chain' the vaccine will rely on.

A volunteer receives an experimental vaccination for the coronavirus as part of a Pfizer clinical trial at the University of Maryland's medical school. University of Maryland Pfizer is piloting delivery options for its COVID-19 vaccine in Rhode Island, Texas, New Mexico, and Tennessee, Reuters reported Tuesday. The vaccine has to be shipped and stored at minus 94 degrees Fahrenheit, which poses major distribution challenges. Moderna's vaccine, by comparison, can be stored in a fridge. ...
Tags: Texas, US, Trends, Tennessee, Healthcare, Ubs, Pfizer, Vaccine, New Mexico, Rhode Island, Reuters, Tennessee Reuters, Moderna, Coronavirus, COVID-19, Coronavirus Vaccine


Moderna and Pfizer's coronavirus vaccines are more than 90% effective. Here's how that compares to shots for the flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. Pfizer announced last week that its coronavirus vaccine candidate was found to be more than 90% effective. The chart below shows how those vaccine candidates' efficacy c...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Vaccines, Anthony Fauci, Johnson Johnson, Moderna


Dow posts first record close since February as Moderna vaccine data spurs optimism

Getty Images / Scott Olson US equities soared on Monday after Moderna's encouraging vaccine update lifted hopes for a complete economic recovery.The Dow Jones industrial average and S&P 500 finished the day at all-time high levels. It marks the Dow's first record close since February.Moderna said Monday that its experimental coronavirus vaccine was 94.5% effective at preventing COVID-19 in trial patients. The biotech company plans to apply for emergency use authorization later this month.T...
Tags: US, Trends, Markets, Netflix, Barclays, Delta, Hotel, Treasury, Oil Price, Goldman Sachs, Pfizer, Airlines, Morgan Stanley, Nasdaq, Goldman, Dow Jones


Dr. Anthony Fauci and Bill Gates: Some coronavirus vaccines may work better in certain populations than others

Dr. Anthony Fauci said a coronavirus vaccine wouldn't be ready until January 2021. Reuters, Al Drago/AFP via Getty Images There won't be just one coronavirus vaccine "winner," but hopefully 4 or 5, Dr. Anthony Fauci told Rashida Jones on the new podcast she hosts with Bill Gates.  Gates and Fauci agreed that some vaccines may be more effective in certain populations than others. Each vaccine may also vary in how effectively it prevents transmission of the virus, which will be "confusin...
Tags: South Korea, Science, Microsoft, Australia, Trends, United States, Bill Gates, Fda, Pfizer, Vaccines, Anthony Fauci, Gates, Rashida Jones, Fauci, Moderna, Getty Images There


Bill Gates says the first thing he'll do after a coronavirus vaccine is hug Bono

Bill Gates and Bono in 2016. GEOFF ROBINS / Stringer Microsoft founder Bill Gates and actress Rashida Jones have a new joint podcast about big global challenges. The first episode focused on the coronavirus.  When asked about the first thing he'll do once life returns to "normal," Gates said he misses people like Bono, whose in-person energy and affection can't be replicated on Zoom. "You're going to go hug Bono, that's the first thing you're going to do," Jones summarized. "Absolutel...
Tags: Science, Podcasts, Microsoft, Bono, Trends, Bill Gates, Fda, Vaccine, Anthony Fauci, Gates, Jones, Rashida Jones, Don, Fauci, Moderna, Coronavirus


Moderna's coronavirus vaccine requires 2 shots given a month apart, which makes it tougher to get everyone fully inoculated

A nurse prepares a coronavirus vaccine developed by Moderna and the National Institutes of Health, July 2020. Hans Pennink/AP Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. The vaccine requires two shots administered four weeks apart, which could make distribution more complicated. People may need additional booster shots later, experts say. Visit Business Insider's homepage for more stories. Two co...
Tags: Health, Science, News, Massachusetts, Trends, Turkey, Astrazeneca, National Institutes of Health, Pfizer, Anthony Fauci, Mount Sinai, Boston Globe, Johnson Johnson, Icahn School of Medicine, Cambridge Massachusetts, NBC s Today


How the biotech upstart Moderna exploded into one of the most important startups of all time, creating a highly effective coronavirus vaccine

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House on March 2, 2020. Andrew Harnik/AP Images In its short corporate history, Moderna has grown accustomed to breaking records.A $450 million funding round in 2015 was a record for the biotech industry. Moderna raised even more the next year. And its 2018 initial public offering was the largest-ever for a biotech, ...
Tags: Health, Science, News, White House, Trends, Healthcare, Pfizer, Donald Trump, Teaser, Biotechnology, Robert Langer, Noubar Afeyan, Moderna, Cabinet Room, Andrew Dunn, Stéphane Bancel


Dow soars 450 points to new record as Moderna's vaccine update boosts investor optimism

Brendan McDermid/Reuters US equities soared on Monday after Moderna's encouraging vaccine update lifted hopes for a complete economic recovery.Moderna announced Monday that its experimental coronavirus vaccine was 94.5% effective at preventing COVID-19 in trial patients. Moderna plans to apply for emergency use authorization later this month.The Dow Jones industrial average hit an intraday record, while the S&P 500 traded less than 1% from its own all-time high.The news specifically lifted...
Tags: US, Trends, Markets, Netflix, Barclays, Delta, Economic recovery, Hotel, Treasury, Oil Price, Pfizer, Airlines, Nasdaq, Goldman, Dow Jones, Gold Price


The man in charge of evaluating coronavirus vaccines for the FDA lays out why it will take weeks to vet a COVID-19 shot

FDA's Dr. Peter Marks Amanda Andrade-Rhoades/Getty Images As coronavirus vaccines inch closer to reality, the man in charge of reviewing the approval applications wants Americans to trust the process. That means we're not going to get surprise Food and Drug Administration approvals in the coming days, despite two COVID-19 vaccine frontrunners announcing success over the past week. The review process will be measured in weeks, Dr. Peters Marks, director of the FDA's center for biologica...
Tags: Health, Science, News, Massachusetts, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Business Insider, EUA, Pharmaceutical, Marks, Steve Parsons, Moderna